Introduction {#s1}
============

Branching MT nucleation is dependent upon Augmin and γ-TuRC and generates the bulk of MTs required for both meiotic and mitotic spindle formation ([@bib19]; [@bib22]; [@bib5]) and has been visualised in vivo in *Drosophila, Xenopus*, plants, and humans ([@bib19]; [@bib5]; [@bib10]; [@bib11]; [@bib16]; [@bib8]; [@bib28]; [@bib21]; [@bib20]). However, understanding, and in vitro reconstitution of, this phenomenon has been hampered by methodological constraints relating to purification of functional protein complexes ([@bib12]; [@bib24]); Augmin is composed of 8 subunits, while the γ-TuRC is a \~ 2 MD protein complex containing multiple copies of at least six proteins, including 14 molecules of γ-Tubulin ([@bib31]; [@bib17]; [@bib15]; [@bib26]; [@bib18]). In vitro studies ([@bib18]) generally use proteins that have been individually- or co-expressed and purified in heterologous systems ([@bib27]; [@bib23]), where folding and post translational modifications crucial to function may not occur. Although purification of protein complexes from autogenous cells can be achieved using affinity-based methods, non-specific binding of contaminating proteins and difficulties in releasing purified proteins from affinity matrices are major problems.

We therefore developed an approach to allow the isolation of intact, functional Augmin and γ-TuRC, to test the hypothesis that these two complexes are necessary and sufficient for branched MT nucleation. The approach is based on biotinylated, amine-reactive thiol- or photo-cleavable linkers, Sulfo-NHS-SS-Biotin and PC-Biotin-NHS ([Figure 1a](#fig1){ref-type="fig"}). Stepwise incubation of the \~12 kD camelid anti-GFP nanobody, GFP-binding protein, with either of these linkers resulted in covalent linkage, while subsequent incubation with a Streptavidin Agarose matrix led to stable tri-partite reagents -- GFP-TRAP-Sulfo beads and GFP-TRAP-PC beads; where GFP-binding protein is immobilised, but cleavable through the addition of DTT or exposure to UV light, respectively ([Figure 1a](#fig1){ref-type="fig"}).

![Isolation of functional γ-TuRC and Augmin using cleavable affinity purification.\
(**a**) Sketch of purification methodology. (**b**) Images of GFP-TRAP-Sulfo beads after incubation with His-GFP, pre- and post-cleavage by 50 mM DTT. (**c**) Western blot demonstrating the effective isolation and cleavage of soluble His-GFP. (**d**) Western blots of cl-AP of Msd1-GFP and γ-Tubulin-GFP. The fusion proteins, present in embryo extracts (input), are efficiently depleted upon incubation with GFP-TRAP-Sulfo beads (unbound), released in 50 mM DTT (post-cleaved beads) and present in the eluate. Subunits of Augmin, but not γ-TuRC, co-elute with Msd1-GFP. Subunits of γ-TuRC, but not Augmin, co-elute with γ-Tubulin-GFP. (**e**). SYPRO-ruby stained gels of post-cleaved eluates from control embryos (OrR), or MG132-treated (mitotic) embryos expressing the Augmin subunit Msd1-GFP or γ-Tubulin-GFP. (**f**) Western blot of sucrose gradient fractionation of purified mitotic Augmin or γ-TuRC. Complexes sediment as expected for their molecular weights. (**g**) Western blots of in vitro MT co-sedimentation assays. In the absence of taxol (-), Tubulin, pure Augmin (Msd1-GFP) and pure γ-TuRC (γ-Tubulin-GFP) remain in the supernatant (S). In the presence of taxol (+), Tubulin polymerises and is present in the pellet (P). Augmin and γ-TuRC co-sediment.](elife-49769-fig1){#fig1}

To test these reagents, beads were incubated with bacterially expressed and purified 6xHis-GFP, and extensively washed. Individual beads fluoresced with varying intensity and, upon brief exposure to 50 mM DTT or UV light, fluorescence decreased, concomitant with an increase in the surrounding medium ([Figure 1b](#fig1){ref-type="fig"}; [Figure 1---figure supplement 1a,b](#fig1s1){ref-type="fig"}). Western blot analysis confirmed \>90% and\~60% of GFP was released from GFP-TRAP-Sulfo and GFP-TRAP-PC beads, respectively, following cleavage ([Figure 1c](#fig1){ref-type="fig"}; [Figure 1---figure supplement 1c](#fig1s1){ref-type="fig"}).

We next sought to determine whether this '[cl]{.ul}eavable [A]{.ul}ffinity [P]{.ul}urification' (cl-AP) could be used to isolate Augmin and γ-TuRC. We have previously shown that *Drosophila* Augmin can be purified from extracts of early embryos expressing a GFP-tagged variant of the Msd1 subunit ([@bib3]). *Drosophila* embryos have also been used to purify the γ-TuRC ([@bib18]; [@bib17]), and flies expressing γ-Tubulin-GFP are available ([@bib9]). As branching MT nucleation is essential during mitosis, we used embryos arrested in a metaphase-like state through incubation with the proteasomal inhibitor, MG132 ([@bib4]). Both Msd1-GFP and γ-Tubulin-GFP were efficiently immobilised on GFP-TRAP-Sulfo or GFP-TRAP-PC beads and western blotting confirmed that, upon cleaving, Msd1-GFP and γ-Tubulin-GFP were concentrated in the eluate, with other subunits of the complexes co-eluting ([Figure 1d](#fig1){ref-type="fig"}; [Figure 1---figure supplement 1d](#fig1s1){ref-type="fig"}). To test the purity of the complexes, we subjected MG132-treated (mitotic) control (OrR), Msd1-GFP or γ-Tubulin-GFP embryo extracts to GFP-TRAP-Sulfo cl-AP followed by gel electrophoresis and SYPRO-ruby staining of eluates ([Figure 1e](#fig1){ref-type="fig"}). Bands corresponding to each subunit of both Augmin and γ-TuRC were identified at intensities expected for the known stoichiometric relationships between subunits ([@bib18]). One additional set of low intensity bands was seen in all eluates, at \~45 kD; almost certainly corresponding to yolk proteins - the most abundant proteins in *Drosophila* early embryos ([@bib1]). Importantly, γ-Tubulin did not co-purify with Augmin, and Dgt3 (a subunit of the Augmin complex) did not co-purify with γ-TuRC ([Figure 1d](#fig1){ref-type="fig"}). Moreover, sucrose gradient analysis undertaken on purified mitotic complexes determined that Msd1-GFP sedimented as expected for Augmin-GFP (\~360 kD) and that γ-Tubulin-GFP sedimented in two populations -- one consistent with γ-Tubulin-GFP alone and one consistent with incorporation into the γ-TuRC (2MD) ([Figure 1f](#fig1){ref-type="fig"}). Neither complex co-fractionated, again strongly suggesting that Augmin and γ-TuRC are purified independently of one another, or other cellular activities.

Both γ-TuRC and Augmin bind MTs in co-sedimentation assays ([@bib13]; [@bib30]; [@bib8]). We therefore incubated mitotic Augmin-GFP or γ-TuRC-GFP with purified Tubulin, in the presence of GTP and taxol to promote MT polymerisation, sedimenting through a glycerol cushion to separate MTs and MT associated proteins from soluble Tubulin and non-MT binding proteins ([Figure 1g](#fig1){ref-type="fig"}; [Figure 1---figure supplement 1e](#fig1s1){ref-type="fig"}). As expected, both Msd1-GFP and γ-Tubulin-GFP co-sedimented with MTs, demonstrating purified Augmin and γ-TuRC maintain at least some of their cellular properties.

To assess the effects of purified Augmin and γ-TuRC on MT nucleation and polymerisation, we used a highly-reproducible quantitative assay, where incorporation of a dye into MTs as they polymerise is measured as a change in fluorescence ([@bib2]) (Cytoskeleton Inc). Incubation of Tubulin in the presence of GTP and glycerol at 37°C resulted in its polymerisation over \~1 hr, with sigmoidal dynamics corresponding to lag, nucleation, polymerisation and plateau phases ([Figure 2a](#fig2){ref-type="fig"}; [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). The time at which 50% of polymerisation was achieved (x50) was 31.5mins (± 0.5 mins) ([Figure 2b](#fig2){ref-type="fig"}). Addition of purified γ-TuRC-GFP stimulated MT nucleation, causing a shift in the polymerisation curve and a reduction in the x50 to 16.5 mins (± 1.2 min) ([Figure 2a,b](#fig2){ref-type="fig"}), confirming its functionality. In contrast, addition of purified Augmin-GFP had no significant effect on the shape of the polymerisation curve or the x50 (32.5 mins (± 1.5 min) ([Figure 2a,b](#fig2){ref-type="fig"}). Therefore, although Augmin-GFP binds MTs it does not, in isolation, change MT nucleation/polymerisation dynamics. However, addition of Augmin-GFP dramatically enhanced γ-TuRC-dependent nucleation of MTs, further reducing the x50 to 9.5 min (± 0.45 min) ([Figure 2a,b](#fig2){ref-type="fig"}). This effect was specific for the physical interaction between Augmin and γ-TuRC, as addition of bacterially expressed and purified truncated Augmin subunits, Dgt3, Dgt5 and Dgt6, which we previously demonstrated interact directly with γ-TuRC ([@bib3]), resulted in nucleation/polymerisation curves indistinguishable to γ-TuRC alone ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). Thus, purified Augmin does, indeed, augment γ-TuRC-dependent MT nucleation in vitro.

![Pure Augmin enhances γ-TuRC-dependent MT nucleation in a cell cycle dependent manner.\
(**a**) Tubulin polymerisation assays, where fluorescence is directly related to the amount of Tubulin polymer present. The curves are a sigmoidal fit to six replicates of the experiment (dots); three independent purification experiments, each undertaken in duplicate. (**b**) Plot of the x50 in relation to control polymerisation assay, showing the median (red line), interquartile ranges (blue box) and 95% confidence intervals of the median (notches) for each condition. The differences in the time taken for 50% polymerisation between all conditions differs significantly at p=0.001, except when comparing control to Augmin (ANOVA). (**c**) Fluorescent tubulin polymerisation assays undertaken with complexes isolated from MG132-treated (mitotic) or cycling embryos.](elife-49769-fig2){#fig2}

Importantly, this phenomenon was dependent on whether the complexes were isolated from mitotically arrested (MG132) or untreated, mainly interphase (cycling) embryos. γ-TuRC purified from cycling embryos was a less efficient nucleator than its mitotic counterpart ([Figure 2c](#fig2){ref-type="fig"}; [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}), while cycling Augmin, like mitotic Augmin, showed no independent activity. However, when incubated together, either mitotic γ-TuRC and cycling Augmin or cycling γ-TuRC and mitotic Augmin were able to enhance MT nucleation to the same extent as both mitotic complexes ([Figure 2c](#fig2){ref-type="fig"}; [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). As cell cycle dependent changes in protein function are determined mostly by post-translational modifications (PTMs), this observation suggests that PTMs of either Augmin or γ-Tubulin are crucial in vivo.

To characterise the morphology of MTs generated in the presence of purified mitotic Augmin and γ-TuRC, we initially took samples from the in vitro assays at t = 15 min, fixing and imaging them via fluorescence microscopy. Control samples, or those containing purified Augmin, showed only very few, short MTs per field of view while, as expected, γ-TuRC-containing samples possessed many individual MTs ([Figure 3a](#fig3){ref-type="fig"}). In contrast, samples incubated simultaneously with γ-TuRC and Augmin showed extensive MT branching, bundling and nesting, rather than individual MTs ([Figure 3a](#fig3){ref-type="fig"}). Moreover, consistent with the observation that, in vivo, Augmin is required for γ-Tubulin localisation to the mitotic spindle, purified mitotic Augmin was able to recruit purified γ-TuRC to MTs in vitro, co-localising along the length of MTs in distinct punctae ([Figure 3---figure supplement 1a](#fig3s1){ref-type="fig"}). To temporally resolve the MT nucleation and polymerisation in the presence of Augmin and γ-TuRC, we fixed reactions at earlier timepoints. Even within 1 min of the simultaneous addition of Augmin and γ-TuRC, MT nucleation and putative branching were observed, though background fluorescence of soluble tubulin was high ([Figure 3b](#fig3){ref-type="fig"}). Samples taken at t = 2 and t = 5 min showed similar numbers of MTs to each other, per field of view, though the mean length of MTs, and proportion of MTs with branches, were significantly greater after 5 min, than after 2 min (4.01 μm versus 3.24 μm and 34% versus 24%, respectively) ([Figure 3b](#fig3){ref-type="fig"}; [Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}). This suggests that MT nucleation from purified γ-TuRCs reaches maximal activity within the first few minutes of the assay. Moreover, the estimated number of γ-TuRCs per coverslip (6.0 x 10^6^) was 2-3 times less than the mean number of MTs per coverslip (1.7 x 10^7^) (see Materials and methods). These calculations suggest ﻿﻿either (i) that our approximations of γ-TuRC molarity are out by a factor of 2-3, (ii) that the MTs counted include a proportion that have been nucleated by a γ-TuRC and subsequently broken or (iii) that a single γ-TuRC is able to nucleate multiple MTs at a rate of \>1 MT/min, perhaps by nucleation and subsequent release.

![Reconstitution of the MT-Augmin-γ-TuRC-MT junction.\
(**a**) Confocal images of fixed, fluorescent polymerisation assays at t = 15 mins for each condition. (**b**) Confocal images of fixed, fluorescent polymerisation assays at t = 1, 2 and 5 mins in the presence of purified Augmin and γ-TuRC. (**c**) Confocal images of taxol stabilised MTs, formed in the absence or presence of purified Augmin and γ-TuRC, and co-incubated. Incubation of Augmin-^488^MTs (green) with γ-TuRC-^Rhod^MTs (red) leads to MT branches. (**d**) Higher magnification of the MT-Augmin-γ-TuRC-MT junctions (arrows). (**e**) Histogram of the percentage of ^Rhod^MTs that terminate precisely at a ^488^MT, generating a branchpoint. (**f**) Distribution of γ-TuRC-^Rhod^MTs junction angles, in relation to Augmin-^488^MTs. (**g**) Confocal images of junctions, using GMPCPP seeds (purple) to distinguish the MT minus ends. Minus ends of γ-TuRC-^Rhod^MTs (red) interact with Augmin-^488^MTs (green). (**h**) Pearson correlation coefficient plot demonstrating a strong positive correlation between the length of Augmin-^488^MTs and the position of γ-TuRC-^Rhod^MT branch points. Scale bars, a-d, 5 μm; scale bar, g, 2 μm.\
Figure 3---source data 1.Excel spreadsheets of the individual data points corresponding to [Figure 3b](#fig3){ref-type="fig"} (number and length of MTs per field of view at t = 2 and t = 5 mins); [Figure 3d](#fig3){ref-type="fig"} (Histogram of % of Rhod-MTs terminating on a 488-MT -- i.e. % of γ-TuRC activity); [Figure 3e](#fig3){ref-type="fig"} (diagram of branch angles); [Figure 3f](#fig3){ref-type="fig"} (branchpoint distance from MT minus end, as assessed by GMPCPP seed).](elife-49769-fig3){#fig3}

Finally, we sought to conclusively reconstitute and visualise the branching MT-Augmin-γ-TuRC-MT junction, and to measure the ability of the purified γ-TuRCs to simultaneously bind MT minus ends and Augmin. To do this, we generated populations of taxol-stabilised fluorescent MTs in the presence or absence of individual mitotic protein complexes, subsequently co-incubating them. Co-incubation of HiLyte Fluor 488-MTs (^488^MTs) with Rhodamine-MTs (^Rhod^MTs) resulted in independent populations of MTs. Occasional examples of ^Rhod^MTs terminating at ^488^MTs were observed, but at a frequency consistent with random placement of MTs on coverslips (\~6%) ([Figure 3b,d](#fig3){ref-type="fig"}; [Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}). Similar results were obtained with fluorescent MTs incubated with either Augmin or γ-TuRC ([Figure 3c,e](#fig3){ref-type="fig"}; [Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}). However, when ^Rhod^MTs incubated with γ-TuRC were added together with ^488^MTs incubated with Augmin, 55% of γ-TuRC-containing ^Rhod^MTs terminated precisely at an Augmin-containing ^488^MT ([Figure 3c--e](#fig3){ref-type="fig"}; [Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}). Although the polarity and angles of the ^Rhod^MTs branches in relation to the 'mother' ^488^MTs varied far more widely than seen in vivo, presumably due to how the MTs settled on the coverslip during preparation, we found a bias in the angle, similar to that seen in living *Drosophila* ([@bib29]) ([Figure 3e](#fig3){ref-type="fig"}; [Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}). To unequivocally demonstrate the polarity of the MTs, and to take into account MTs that might have lost their native γ-TuRC-bound minus end during sample preparation, we formed these junctions in the presence of pre-stabilised HiLyte 647-labelled GMPCPP MT seeds. As expected, the polarity of the interaction between γ-TuRC-^Rhod^MTs and Augmin-^488^MTs was specific; with only the minus ends of γ-TuRC-^Rhod^MTs precisely terminating at the Augmin-^488^MTs lateral surfaces ([Figure 3g](#fig3){ref-type="fig"}). Moreover, as predicted, the percentage of γ-TuRC-^Rhod^MTs generating branches further increased to 64% ([Figure 3e](#fig3){ref-type="fig"}; [Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}). Finally, we found that the formation of junctions on Augmin-containing ^488^MTs was length independent -- branches were equally distributed at the very distal MT tips, throughout their length and on the GMPCPP seed itself ([Figure 3g,h](#fig3){ref-type="fig"}; [Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}).

Our work confirms a long-standing hypothesis, first articulated to explain the loss of γ-Tubulin on the mitotic spindle when the expression of Augmin subunits is reduced ([@bib7]). It demonstrates conclusively that Augmin directly recruits γ-TuRC to MTs and that these two protein complexes are sufficient for robust and efficient branching MT nucleation. Although our calculations suggest that 65% of the mitotic γ-TuRCs are competent to bind MT minus ends and Augmin, and that they are able to nucleate at a rate of \>1 MT/min, we expect that, in vivo, other proteins further enhance these γ-TuRC activities. For example, a clear role has been reported for the MT associated protein, TPX2, in stimulating Augmin-dependent branched MT nucleation in *Xenopus* meiotic extracts ([@bib20]; [@bib25]). However, in support of our conclusions, *Drosophila* TPX2 has recently been shown to be dispensible for the phenomenon in vivo ([@bib29]). Our experiments also highlight the intriguing possibility that, in some cells, Augmin might recruit pre-existing γ-TuRC-containing MTs, nucleated elsewhere in the cell, anchoring them to specific sites and increasing local MT density.

The generation of stable MT-Augmin-γ-TuRC-MT junctions using the methodologies pioneered here also provide a route to finally defining the molecular detail of MT branching at the ultrastructural level. More broadly, cleavable affinity purification provides the basis to generate more complex, but molecularly defined, mixes of purified proteins, complete with in vivo PTMs, in order to reconstitute higher-order aspects of spindle formation. Indeed, by isolating and combining purified, active proteins and protein complexes from any biological system of interest, \"cl-AP TRAP\" overcomes the limitations of traditional 'bottom-up' approaches, allowing exploration of the level of biological organisation between individual protein and biological process -- the level at which emergence of cellular phenomena often occurs.

Materials and methods {#s2}
=====================

*Drosophila* husbandry and embryo collection {#s2-1}
--------------------------------------------

Flies were kept on standard medium and grown according to standard laboratory procedures. w1118 or Oregon R (OrR) strains (Bloomington Stock Center) were utilized as a wild-type controls. Transgenic flies used were: pUAS-Msd1-GFP; maternal-α-Tubulin-Gal4 ([@bib2]) and pNcd(γ−Tub37C-GFP), a gift from Sharyn Endow ([@bib4]). 0--3 hr old embryos were collected from apple juice/Agar plates, dechorionated using bleach, washed, flash frozen in liquid nitrogen and stored at −80*°*C. For MG132 treatment, embryos were incubated in a solution containing 66.5% PBS (Melford), 33.2% heptane (Sigma) and 0.3% MG132 (Sigma) for 20 mins, prior to rinsing and flash freezing as above. Each embryo collection resulted in 0.05--0.1 g of frozen embryos, different batches of which were combined for each biochemical assay/purification. Routinely, batches of MG132-treated embryos were fixed and stained to visualise chromosomes and MTs, to verify their mitotic arrest.

Preparation of GFP-TRAP-PC and GFP-TRAP-Sulfo beads {#s2-2}
---------------------------------------------------

To prepare GFP-TRAP-Sulfo beads, 200 μL of GFP-binding protein (1 mg/mL) (Chromotek) in PBS was incubated with 86.1 μl of Sulfo-NHS-SS-Biotin (sulfosuccinimidyl-20(biotinamido)ethyl-1,3-dithiopropionate) (8 mM) (Thermo Scientific) for 2 hr at 4°C. Unreacted linker was removed by desalting. 40 μL of High Capacity Streptavidin Agarose Resin (Pierce) was washed 3 times for 5 mins in PBS and incubated with the GFP-binding protein-SS-Biotin product for 1 hr at 4°C with gentle rotation. The beads were washed 3 times for 5 mins in BRB80 + 0.1% IGEPAL, the volume of BRB80 was reduced to 40 μL (to maintain a 50% bead slurry) and beads stored at 4°C for use. A similar protocol was used to generate GFP-TRAP-PC-Biotin-NHS beads, but using 50 μL of GFP-binding protein, incubated with 1.45 µL of PC-Biotin-NHS (50 mM) (Ambergen) for 40 min at RT with gentle rotation and 400 µL of standard Streptavidin-Agarose bead slurry (Sigma Aldrich). Over the course of the project, different conditions were tried in an attempt to increase the photo-cleaving of GFP, Augmin-GFP and γ-TuRC-GFP from the GFP-TRAP-PC beads. We were unable to consistently reach cleaving efficiencies of greater than 60%. In contrast, cleavage of proteins and complexes from GFP-TRAP-Sulfo-beads reproducibly gave efficiencies of \>90% (n =\> 10).

Cleavable affinity purification {#s2-3}
-------------------------------

*Drosophila* embryo High Speed Supernatant (HSS) was prepared using batches of frozen 0--3 hr embryos. Embryos were dounce homogenised in BRB80 + 0.1% IGEPAL + 1 mM PMSF (Sigma), PhosSTOP phosphotase inhibitors and cOmplete, Mini, EDTA free protease inhibitors (Roche) at a ratio of 100 mg embryos to 200 μL buffer. Extracts were clarified through centrifugation at: 17,000 g for 10 min, 100,000 g for 10 min, and 100,000 g for a further 30 min. 6xHis-GFP was purified from bacteria expressing pQE80-His-GFP, using standard protocols and HisPur Cobalt Resin (Thermo Scientific), and dialysed into BRB80 + 0.1% IGEPAL + 1 mM PMSF.

Typically, HSS from 200 mg embryos or 6xHis-GFP (100 ng) were incubated overnight at 4°C with 20 μL of either GFP-TRAP-PC or GFP-TRAP-Sulfo beads. For SYPRO-Ruby staining (see below) HSS from 1 g of embryos expressing either Msd1-GFP or γ-Tubulin-GFP were used, incubated with 50 μL of GFP-TRAP-Sulfo beads. Beads were centrifuged at 2500 g for 2 mins and the depleted supernatant removed and discarded, or used for Western blotting. For cleaving of Sulfo-beads, beads were washed 4 times for 5 mins in BRB80 + 0.1% IGEPAL, resuspended in 25 μL of BRB80 + 0.1% IGEPAL, prior to addition of 25 μL of 100 mM DTT in BRB80 0.1% IGEPAL for 5 mins (50 mM final concentration). For PC-beads, beads were washed as above, then transferred to a microscope slide with a concave cavity with 25 μL of BRB80 0.1% IGEPAL. The slide was placed 10 cm below a UV lamp (UVP XX-15L (Analytik Jena US)) and exposed for 30 s intervals with gentle mixing between. Eluates were removed using a Gel-Saver II pipette tip (STARLAB). Cleaved beads were washed 4 times for 5 min in BRB80 0.1% IGEPAL. After each purification, samples were taken for SDS-PAGE and Western blotting alongside known amounts of 6xHis-GFP, in order to quantify yield and concentration of purified complexes.

Calculation of the molarity of augmin and γ-TuRC following cl-AP {#s2-4}
----------------------------------------------------------------

### Estimation of the concentration of GFP {#s2-4-1}

Western blotting from 6 independent experiments estimates that cl-AP from \~200 μg of either Msd1-GFP or γ-Tubulin-GFP 0--3 hr embryo extract results in soluble complexes containing the equivalent of 8--9 ng of His-GFP per 1 μl. His-GFP has a molecular weight of 28 kD, therefore one mole of GFP weighs 28000 g. Given number of molecules in a mole is 6.02 × 10^23^, 8.5 ng of GFP contains 1.8 × 10^11^ molecules of GFP. The number of moles of GFP in 1 litre is therefore (1.8 × 10^11^×1 × 10^6^) and the molar concentration is 300 nM.

### Estimation of the concentration of purified Augmin {#s2-4-2}

Sucrose gradient sedimentation followed by western blotting demonstrates that all Msd1-GFP in the purified supernatant isolated from GFP-Msd1 expressing embryos is present in fractions consistent with incorporation into Augmin ([Figure 1f](#fig1){ref-type="fig"}). Therefore, the number of Augmin complexes in 1 μl of cl-AP supernatant, isolated from GFP-Msd1 expressing embryos, is 1.8 × 10^11^ and the molar concentration of Augmin is 300 nM. The final concentration of Augmin in the MT co-sedimentation assay was 60 nM (10 μl in 50 μl total), while the final concentration of Augmin in the MT polymerisation assays was 30 nM (5 μl in 50 μl total).

### Estimation of the concentration of purified γ-TuRC {#s2-4-3}

cl-AP from GFP-γ-Tubulin expressing embryos resulted in a mixed population of GFP-γ-Tubulin that is either incorporated into a γ-TuRC, or monomeric (partially folded, or folded but not incorporated). Sucrose gradient sedimentation followed by western blotting estimates that 60% of the GFP-γ-Tubulin in the purified supernatant isolated from GFP-γ-Tubulin expressing embryos is present in fractions consistent with incorporation into γ-TuRCs, while 40% is present in fractions consistent with γ-Tubulin that is not part of the γ-TuRC ([Figure 1f](#fig1){ref-type="fig"}). Purified γ-TuRCs contain \~14 molecules of γ-Tubulin^17^. As GFP-γ-Tubulin expressing embryos also contain endogenous γ-Tubulin, the γ-TuRCs isolated by cl-AP will be a mixed population. Western blotting of purified supernatant isolated from GFP-γ-Tubulin expressing embryos using anti−γ-Tubulin antibodies estimates that 75% of the γ-Tubulin is present as GFP-γ-Tubulin while 25% is present as γ-Tubulin with no tag ([Figure 1---figure supplement 1f](#fig1s1){ref-type="fig"}). Therefore, we estimate that the purified GFP-γ-TuRCs contain 8--10 molecules of GFP-γ-Tubulin (average 9) and 4--5 molecules of unlabelled γ-Tubulin. The molar concentration of γ-TuRC purified by cl-AP is therefore 300 nM x 0.6/9 = 20 nM, or the equivalent of 1.8 × 10^11^×0.6/9 = 1.2×10^10^ γ-TuRCs per 1 μl. The final concentration of γ-TuRC in the MT co-sedimentation assay was 4 nM (10 μl in 50 μl total), while the final concentration of γ-TuRC in the MT polymerisation assays was 2 nM (5 μl in 50 μl total).

### Estimation of the nucleation efficiency of purified γ-TuRC in vitro {#s2-4-4}

1 μl of polymerisation assay containing 2 nM γ-TuRC and 30 nM Augmin at t = 1, 2 or 5 min post-initiation was fixed in 200 μl glutaraldehyde fixation fix. 1 μl of this was spotted onto a 22x22 mm coverslip and imaged. We therefore estimate the total number of γ-TuRCs per coverslip as 6.0 × 10^6^. After two mins post-initiation, an average of 130 MTs were observed per field of view (60.5 μm^2^) ([Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}). Given there are \~1.32×10^5^ fields of view per coverslip, this equates to 1.7 × 10^7^ MTs per coverslip. Therefore, one γ-TuRC is capable of nucleating 2--3 MTs within 2 mins.

SDS-PAGE and western blot analysis {#s2-5}
----------------------------------

Protein samples were fractionated by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE). SYPRO Ruby Staining (Invitrogen) of Augmin and γ-TuRC was undertaken according to manufacturer's instructions. For Western analysis, the proteins were blotted onto a nitrocellulose membrane and probed with anti-GFP (1:1000; Sigma-Aldrich and Roche), anti-dgt6 (1:500) (a gift from M. Gatti), or anti-Dgrip91 antibodies (1:1000) (a gift from Y Zheng). IRDye 800CW goat anti-rabbit (LI-COR) and IRDye 680RD goat anti-mouse (LI-COR) IgG polyclonal Abs were used as secondary detection antibodies. Fluorescence from blots was developed with the Odyssey CLx Imaging System (LI-COR) according to the manufacturer's instructions.

### Sucrose gradient fractionation {#s2-5-1}

2 ml sucrose gradients were formed by layering steps (200 μL each) of 5% to 50% sucrose in BRB80 (5% steps). 15 μL of 300 nM purified Augmin-GFP or 20 nM γ-TuRC-GFP was loaded on to each gradient and spun at 55,000 rpm for 3 hr at 4°C in a TLS-55 rotor (Beckman Coulter). Ten fractions of 180 μL were collected in each gradient from top (fraction 1) to bottom (fraction 10) and, after precipitation with 10% TCA, analysed by SDS-PAGE followed by immunoblotting for GFP. As standards, carbonic anhydrase (29 KDa), Apoferritin (443 Kda), and Blue dextran (2 MD) (Sigma) were subjected to the gradients and samples analysed by SDS-PAGE and Coomassie brilliant blue staining.

In vitro microtubule co-sedimentation assay {#s2-6}
-------------------------------------------

Purified proteins/cl AP eluates were pre-spun at 100,000 g for 15 min at 4°C. 10 μL 300 nM GFP, 300 nM Augmin-GFP or 20 nM γ-TuRC-GFP were incubated for 15 min at 37°C in General Tubulin Buffer with 2.25 mg/mL of 99% pure porcine tubulin and 1 mM GTP (all from Cytoskeleton Inc), in a final volume of 50 μL. Taxol (Sigma) was added to 100 µM and samples incubated for a further 10 min at 37°C. A negative control for each sample was run in parallel, where samples were incubated at 4°C and where GTB replaced taxol. Samples were immediately spun through a 150 µL cushion of BRB80 40% glycerol at 100,000 g for 45 min at 4°C in a TLA120.1 rotor (Beckmann Coulter). The supernatant and pellet fractions were analysed by Western blotting, probing with mouse anti-GFP (Roche) and anti-α-Tubulin antibodies \[DM1A\] (Sigma). Co-sedimentation assays were undertaken in triplicate, each with independently purified Augmin or γ-TuRC. A representative western is shown.

MT polymerization assays {#s2-7}
------------------------

MT polymerization assays were performed using a fluorescence-based Tubulin Polymerization kit (Cytoskeleton Inc, Denver CO, Cat. \# BK011P) following the manufacturer's instructions. Briefly, 5 μL of 300 nM GFP, 300 nM Augmin-GFP or 20 nM γ-TuRC-GFP was pipetted into wells within a 96-well microtiter plate, followed by 45 μL of Tubulin Reaction Mix. Tubulin polymerization was initiated by transferring the plate to a 37°C chamber of a plate reader. The polymerization dynamics of Tubulin were monitored for 60 min at 37°C by measuring the change in fluorescence every 1 min using a TECAN infinite 200pro fluorimeter, at excitation of 350 nm and emission of 440 nm. Assays to assess the effect of purified Augmin and γ-TuRC presented in [Figure 2A](#fig2){ref-type="fig"} are the summation of 3 individual purifications of each protein complex, undertaken in duplicate wells (six data points). Assays to assess the difference in polymerization between cycling and MG132 purified Augmin and γ-TuRC, presented in [Figure 2C](#fig2){ref-type="fig"} are the summation of triplicate experiments. In vitro polymerization assays to assess the difference in Augmin-dependent polymerization upon addition of competing truncated Augmin subunits ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}) are the summation of triplicate experiments.

Generation of fluorescent MTs {#s2-8}
-----------------------------

Tubulin Polymerization assays were performed as described above, but with the following modifications: Rhodamine- or HiLyte Fluor 488-tubulin was used (Cytoskeleton, Inc, Denver, CO) at a 1:10 ratio with unlabelled porcine tubulin (final tubulin concentration, 2 mg/ml). At t = 1, 2, 5 or 15 min, 1 μl of polymerisation sample was added to 200 μl glutaraldehyde (0.5% final concentration in GTB + 1 mM GTP) and incubated at RT for 15 mins. 1 μl of these fixed MTs *were spotted onto glass coverslips* and imaged.

To generate fluorescent, taxol-stabilised MTs, Rhodamine- or HiLyte Fluor 488-tubulin was polymerized as above, but in the absence of purified complexes, but in the presence of taxol at a final concentration of 20 μM. After 7 mins, the taxol-stabilized MTs were removed from the well and incubated with 5 μL of 300 nM Augmin-GFP, 20 nM γ-TuRC-GFP or buffer for 10 min at room temperature. Samples were then layered over a 150 μL cushion of 15% glycerol in BRB80 and centrifuged at 135,000 × g for 10 mins at 25°C in a TLA120.1 rotor (Beckmann Coulter). The MT pellets were gently resuspended in 50 μL of General Tubulin Buffer containing 1 mM GTP and 30% glycerol, combined as necessary as 1:1 mixtures and incubated for 10 min at room temperature. The samples were fixed with glutaraldehyde (0.5--2% final concentration) and spotted onto glass coverslips as above. Images were taken from randomly distributed fields of the coverslips using a Leica TCS SP8 confocal laser scanning microscope. Representative images from one of three independent experiments are shown.

For experiments to visualise MT polarity, HiLyte 647-labelled GMPCPP MTs were generated according to the manufacturer's instructions (Jena Biosciences). Seeds were added to the polymerisation reactions at a 1:10 ratio and processed as described above. Images were taken from randomly distributed fields of the coverslips using a Leica TCS SP8 confocal laser scanning microscope. Representative images from one of two independent experiments are shown.

Imaging and image analysis {#s2-9}
--------------------------

Samples were imaged using an inverted Leica TCS SP8 confocal laser scanning microscope using a HCOL APO CS2 63x, NA 1.4 oil immersion lens (Leica, Wetzlar, Germany). Standard filter sets were used to visualize Rhodamine, HiLyte Fluor 488, and HiLyte Fluor 647 fluorescence. Images were captured as TIFFs using Leica Application Suite X (LAS X), opened in FIJI and levels adjusted to maximise the full range of pixel intensities. To estimate the number of MTs nucleated by purified γ-TuRC and Augmin at different timepoints during the polymerization assay, images were despeckled, a duplicate, segmented mask (otsu method) applied and a minimum size threshold of 0.4 μm (to filter non-MT background) was set. After skeletonizing, the average length of the identified MTs was calculated for 10 fields of view at both t = 2 and t = 5. To quantify the % of ^488^MTs with ^Rhod^MT branches, 8 fields of view of each sample were randomly captured. ^488^MTs over \~1 μM length in each field of view were totaled, alongside the number of ^Rhod^MTs whose fluorescence terminated precisely at a HiLyte^488^MT lateral surface (between 243--339 ^488^MTs per sample condition). To quantify the position of the branchpoints relative to the minus ends of MTs, the length of HiLyte^647^ GMPCPP-containing ^488^MTs were measured using the line tool in ImageJ. The position of the ^Rhod^MT branch from the minus end of these MTs, was also measured. The two sets of variables were subjected to Pearson correlation coefficient analysis using an on-line tool (<https://www.socscistatistics.com/tests/pearson/default2.aspx>), providing the graph in [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}. The Pearson correlation coefficient was r = 0.9962 at a p value of \< 0.00001.

Statistical analysis of polymerisation curves {#s2-10}
---------------------------------------------

Polymerisation data sets were fitted using a sigmoidal function. This characterised each data set in terms of the maximum and minimum fluorescence, the x value (min) at 50% distance between maximum and minimum y fluorescence value (termed 'x50') and the slope. The mean x50 value for the control samples (n = 6) was x = 31.99 (minutes) and y = 2411 (fluorescence a.u.). This value was used as a fix point to compare all the data sets. A one-way ANOVA was performed to compare the four variables (control, Augmin, γ-TuRC, and Augmin+γ-TuRC), with each variable having six repeats. A *post-hoc* Tukey test showed that all variables were significantly different from each other at p=0.001 apart from the control and Augmin, which were not significantly different from each other. Similar analyses were undertaken for the comparison of polymerisation datasets between complexes isolated from MG132 and cycling embryos, and the augmenting activity of Augmin in the presence of truncated Dgt3, Dgt5 and Dgt6 proteins. All fitting and analyses were performed in MATLAB. The code and data can be found at <http://www.github.com/charliejeynes/microtubules> ([@bib14]; copy archived at <https://github.com/elifesciences-publications/microtubules>).
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

**Acceptance summary:**

Branching microtubule nucleation from the lateral surface of pre-existing microtubules has emerged as an important nucleation mechanism contributing, for example, to mitotic and meiotic spindle assembly and to microtubule organization in post-mitotic neurons. In this manuscript the authors show that the previously identified main players, augmin and γ-TuRC, purified as native protein complexes from *Drosophila* embryo extract, are sufficient to reconstitute branching nucleation in vitro. It is further shown that augmin stimulates γ-TuRC nucleation activity in a cell cycle-dependent manner. These are important conceptual advances in our understanding of fundamental cell biological processes. By establishing the minimally required components and revealing a regulatory activity, this manuscript also provides the framework and tools for further analyses in future studies.

**Decision letter after peer review:**

Thank you for submitting your article \"in vitro reconstitution of branched microtubule nucleation\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, including Jens Lüders as the Reviewing Editor and Reviewer \#1, and the evaluation has been overseen by Anna Akhmanova as the Senior Editor.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

The paper \"in vitro reconstitution of branched microtubule nucleation\" by Tariq et al. presents the biochemical reconstitution of microtubule nucleation from the lattice of pre-existing microtubules. Using affinity purification from *Drosophila* embryo extract the study suggests that purified augmin and γ-TuRC, two multi-subunit protein complexes previously implicated in branching nucleation, are sufficient for this activity.

The reconstitution of branching nucleation from purified proteins is a major achievement. A weakness of the study is that the visualization of branched nucleation in fixed samples is not very convincing and that the authors have never looked at the branching nucleation process by real-time imaging; it would have been a doable experiment assuming the authors had access to a TIRF microscope. On the other hand, all reviewers agree that a unique aspect of this study is that, by collecting embryos in mitosis and interphase, the authors directly compared the augmin and γ-TuRC activities of both phases. This is not easily achievable by approaches utilizing recombinant proteins. Moreover, the finding that augmin stimulates γ-TuRC dependent nucleation would also be an important contribution to our understanding of branching nucleation.

Essential revisions:

In summary, while the study represents an important advance, it is not fully convincing in its current form. The authors need to improve the quality of the branching nucleation assay, include quality controls for the purified protein complexes and provide an estimate of the efficiency of the reconstitution. This is crucial since reconstitution with low efficiency may indicate that an important factor is missing.

1\) The demonstration of reconstituted branching nucleation in Figure 3A needs to be improved. Tubulin appears to form aggregates rather than clear branches. If real-time imaging cannot be provided, another possibility is to perform the assay on pre-assembled MTs. These could be labeled in one color and then, after addition of augmin and γ-TuRC, the nucleated branches could be labeled with tubulin of a different color.

2\) Throughout the manuscript, the authors refer to \"pure\" proteins, for example \"pure Augmin.\" However, none of the protein reagents are pure as would be revealed by analysis by mass spectrometry. Therefore \"pure\" should be replaced with \"purified\" or \"enriched.\" Following the same reasoning, the statement -- \"It demonstrates conclusively that Augmin directly recruits γ-TuRC to MTs and that these two protein complexes are sufficient for the phenomenon of branched MT nucleation.\" cannot be made. This issue could be potentially resolved by demonstrating a high efficiency of the reconstitution (see point 3 below) and by ensuring the quality of the purified complexes. The authors should at least show that they purify complexes of the expectd size (e.g. by gel filtration or sucrose gradient analysis) and also probe purified augmin with γ-TuRC antibodies and purified γ-TuRC with augmin antibodies to exclude significant co-purification. It is also important to compare size and composition of preparations from the two different cell cycle stages that are used in the assays. Gels are only shown for \"interphase\" augmin and γ-TuRC.

3\) Please indicate protein concentrations used in each experiment in a reader-friendly manner (provide nM or µM instead of providing volume and mass). The authors should provide an estimate of the efficiency of the branched nucleation, the fraction of γ-TuRC that is active.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"in vitro reconstitution of branching microtubule nucleation\" for further consideration at *eLife*.

The reviewers have evaluated your revisions and have noted that an important issue raised in the first round of review was not addressed. It concerns the estimation of the specific activity of gTuRC in the branching nucleation assay (assay in Figure 3A). As outlined in the previous decision letter and in the follow-up clarification, the reviewers feel that without this information it is difficult to assess if the reconstituted system is complete. It seems that in your revision you have provided an alternative quantification, the efficiency of branch site formation from preformed MT/augmin and MT/gTuRC complexes. However, this is not a measure of the gTuRC nucleation activity.

Before coming to a decision, we would like to ask if you can obtain this data and add it to your revised manuscript?

10.7554/eLife.49769.sa2

Author response

> Essential revisions:
>
> In summary, while the study represents an important advance, it is not fully convincing in its current form. The authors need to improve the quality of the branching nucleation assay, include quality controls for the purified protein complexes and provide an estimate of the efficiency of the reconstitution. This is crucial since reconstitution with low efficiency may indicate that an important factor is missing.
>
> 1\) The demonstration of reconstituted branching nucleation in Figure 3A needs to be improved. Tubulin appears to form aggregates rather than clear branches. If real-time imaging cannot be provided, another possibility is to perform the assay on pre-assembled MTs. These could be labeled in one color and then, after addition of augmin and γ-TuRC, the nucleated branches could be labeled with tubulin of a different color.

We were unable to obtain live image series of sufficient quality using our current TIRF set up and methodology (probably due to technical considerations, such as required surface passivation and optimisation of fluorescent tubulin concentrations). We therefore spent significant time over the last two months developing an alternative live branching assay, in collaboration with Remy Chait, a recently appointed Living Systems Institute lecturer in microfluidics. We are encouraged by our progress but, unfortunately, we are not yet at a point at which we can robustly image branched nucleation using our purified components to the quality expected for *eLife*. We also contacted Thomas Surrey, with whom we have had conversations in the past about live imaging of MTs. However, given Thomas' imminent move to Barcelona, he was unable to assist in the timeframe required.

As an alternative, we have, therefore, re-performed the fixed analysis of dynamic branched MT nucleation, taking samples at 1, 2 and 5 minutes after initiation, fixing with glutaraldehyde and imaging. We believe these images, now incorporated into a revised Figure 3 (Figure 3B), very clearly demonstrate the progressive morphological changes of MT nucleation, showing MT branching within 2 minutes of simultaneous addition of Augmin and γ-TuRC, and leading nicely on to the latter panels, where we used pre-assembled fixed MTs and both two and three colour imaging.

> 2\) Throughout the manuscript, the authors refer to \"pure\" proteins, for example \"pure Augmin.\" However, none of the protein reagents are pure as would be revealed by analysis by mass spectrometry. Therefore \"pure\" should be replaced with \"purified\" or \"enriched.\"

A very fair point. We have replaced these instances as asked.

> Following the same reasoning, the statement \"It demonstrates conclusively that Augmin directly recruits γ-TuRC to MTs and that these two protein complexes are sufficient for the phenomenon of branched MT nucleation.\" cannot be made. This issue could be potentially resolved by demonstrating a high efficiency of the reconstitution (see point 3 below) and by ensuring the quality of the purified complexes. The authors should at least show that they purify complexes of the expectd size (e.g. by gel filtration or sucrose gradient analysis) and also probe purified augmin with γ-TuRC antibodies and purified γ-TuRC with augmin antibodies to exclude significant co-purification. It is also important to compare size and composition of preparations from the two different cell cycle stages that are used in the assays. Gels are only shown for \"interphase\" augmin and γ-TuRC.

We have now more fully assessed the purity of the complexes to allow us to maintain the conclusion we drew in the original submission. As requested, we have undertaken sucrose gradient analysis for each of the two purified complexes, Augmin and γ-TuRC, for each cell cycle stage and probed purified complexes to exclude significant co-purification of Augmin and γ -TuRC. We present these in a revised Figure 1. So, in Figure 1D, we now include western blots of MG132 (mitotic) Augmin and γ-TuRC purifications, probed with reciprocal antibodies. This clearly demonstrates that subunits of neither complex co-purify with each other. In addition, in Figure 1F, we show the results of sucrose gradients undertaken from MG132 (mitotic) Augmin and γ-TuRC purifications, probed with anti-GFP. These results show that Msd1-GFP sediments as expected for Augmin-GFP (\~360kD) and that γ-Tubulin-GFP sediments in two populations -- one consistent with γ-Tubulin-GFP alone and one consistent with incorporation into the γ-TuRC (2MD). Neither overlap with each other, again strongly suggesting that these two complexes are purified independently -- and independently of additional activities. We now mention these results in the text.

We have undertaken similar sucrose gradients for Augmin and γ-TuRC purified from interphase/cycling embryos. As they show similar profiles and as our focus here is on the activity of mitotic Augmin and γ-TuRC we have chosen not to show these in the Figure. If the reviewers feel it is important to show the similar sucrose gradient profiles, we will incorporate those panels into a further Supplementary Figure.

Finally, to clarify, the SYPRO-ruby gels shown in Figure 1 are for the "mitotic" Augmin and γ-TuRC, not interphase.

> 3\) Please indicate protein concentrations used in each experiment in a reader-friendly manner (provide nM or µM instead of providing volume and mass).

Within the manuscript text, we have now provided the estimated protein concentrations used in each experiment in nM. We have also provided a summary of how we arrived at these concentrations within the Materials and methods, and a detailed explanation the calculations as Materials and methods subsection \"Calculation of the molarity of Augmin and γ-TuRC following Cl^-^AP\". The sucrose gradient results (now shown in Figure 1F; see point above) were used to determine the proportion of Msd1-GFP and γ-Tubulin-GFP incorporated into Augmin and γ-TuRC respectively. For purified Augmin, protein concentration can be directly arrived at through comparison with the concentration of GFP moiety, as all the Msd1-GFP was found to be incorporated in a complex of the expected size of Augmin. This provides an estimate of purified Augmin concentration of 300nM.

However, estimation of the concentration of γ-TuRC requires both an estimation of the proportion of γ-Tubulin-GFP incorporated into γ-TuRC -- obtained from the sucrose gradients (\~60% in TuRC and 40% monomeric) -- and an estimation of the number of molecules of γ-Tubulin-GFP within the γ-TuRCs. Purified γ-TuRCs contain \~14 molecules of γ-Tubulin. As the γ-Tubulin-GFP expressing embryos also express endogenous γ-Tubulin, the γ-TuRCs isolated by Cl^-^AP will be heterogeneous. We have now included a western blot of post-cleaved eluate isolated from γ-Tubulin-GFP expressing embryos, probed with anti- g-Tubulin antibodies (Figure 1---figure supplement 1F). This provides an estimate that \~75% of the γ-Tubulin is present as γ-Tubulin-GFP while 25% is present as γ-Tubulin with no tag. Therefore we estimate that the purified γ-TuRCs contain, on average, 8-10 molecules of γ-Tubulin-GFP and 4-5 molecules of unlabelled γ-Tubulin. Therefore, we estimate the molar concentration of γ-TuRC purified by Cl^-^AP under the conditions described, as 300nM x 0.6/9 = 20nM.

> The authors should provide an estimate of the efficiency of the branched nucleation, the fraction of γ-TuRC that is active.

We believe the co-incubation of taxol stabilised Alexa488-MTs + mitotic Augmin with Rhod-MTs + mitotic γ-TuRC, reported in our original Figure (B,C,F), provides us with the perfect experiment with which to answer this question. Based on the concentrations of the protein complexes in our assay and the number of MTs per field of view, we predict that every Rhod-MT minus end should have a γ-TuRC bound to it, and that Augmin-dependent γ-TuRC binding sites on Alexa488 MTs are in excess. Therefore, the ratio of Rhod-MTs terminating precisely at an Alexa488 MT against the total number of Rhod-MTs provides an estimate of the fraction of γ-TuRCs that are active (where activity is defined as the ability of a γ-TuRC to simultaneously bind Augmin and the minus end of a MT). We have modified Figure 3D -- the histogram that originally detailed the% of Alexa488 MTs with Rhod MT branches; it now measures and represents the% of Rhod MTs that terminate at an Alexa488 MT.

This quantification demonstrates that, in the presence of Alexa488-MTs+Augmin, 55% of Rhod-MTs+γ-TuRC form branches. Moreover, when repeated using the Alexa633-GMPCPP-MT seeds, labelling the minus ends of the Rhod MTs, the percentage increases to 64%. This probably reflects a proportion of Rhod MTs that break during the preparation process, losing their native γ-TuRC-bound minus end. Thus, we conclude that the fraction of γ−TuRC that is active in our assays is at least 64%.

We have altered the manuscript to reflect the above result, commenting that while it is still possible that other proteins in the cell either further enhance the ability of g-TuRC to bind Augmin, or increase the dynamics with which it is able to nucleate MTs, it is clear that mitotic γ-TuRC, isolated from *Drosophila* embryos using Cl^-^AP is sufficient for robust and efficient branched MT nucleation in vitro.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

> The reviewers have evaluated your revisions and have noted that an important issue raised in the first round of review was not addressed. It concerns the estimation of the specific activity of gTuRC in the branching nucleation assay (assay in Figure 3A). As outlined in the previous decision letter and in the follow-up clarification, the reviewers feel that without this information it is difficult to assess if the reconstituted system is complete. It seems that in your revision you have provided an alternative quantification, the efficiency of branch site formation from preformed MT/augmin and MT/gTuRC complexes. However, this is not a measure of the gTuRC nucleation activity.

We agreed with the reviewers that we would count the number of MTs nucleated in the gTuRC+Augmin polymerisation assay at early timepoints, specifically t=2 and t=5 minutes. These would then directly correlate with the panels shown in Figure 3B from our previously revised manuscript. Given that, in our initial Response, we estimated the number of gTuRCs per ul of eluate, we could then relate the number of gTuRCs per field of view, with the number of MTs nucleated in that field of view. This would give a measure of nucleation activity.

Results:

Measuring the number of MTs at t=2 mins of the polymerisation assay

We obtained data from 10 fields of view from both t=2 and t=5 minutes in the polymerisation assay, counting the number of MTs using Image J. We also manually counted the number of branching MTs, providing this as a percentage of total MTs. Finally, we used Image J to automatically segment and measure the length of the MTs at each time point.

We describe this experiment in a revised section:

"Samples taken at t=2 and t=5 minutes showed similar numbers of MTs to each other, per field of view, though the mean length of MTs, and proportion of MTs with branches, were significantly greater after 5 minutes, than after 2 minutes (3.24 μm versus 4.01 μm and 34% versus 24%, respectively) (Figure 3B; Figure 3---source data 1). This suggests that MT nucleation from purified γ-TuRCs reaches maximal activity within the first few minutes of the assay".

In the Materials and methods under "Image and Image analysis", we detail how the above values were measured.

In the raw tabular data file, we now add the measurements within a new, appropriately labelled, sheet. We have also edited the legend for this file.

Measuring the activity of the purified gTuRCs

We then go on to use these values to calculate the activity of the gTuRCs, in the following manner:

In our previously revised manuscript, we calculated the number of molecules of GFP per ul of Cl^-^AP eluate (8.5ng) as 1.8x1011. We used this to estimate the number of molecules of purified g-TuRC, taking into account that \~9 of the g-Tubulin molecules in a purified TuRC is present as GFP-g-Tubulin (via Western blotting) and that 60% of the GFP-g-Tubulin purified is present as part of g-TuRCs (via sucrose gradient fractionation).

Therefore, we estimate that the number of molecules of g-TuRC in 1 μl of eluate is 1.8x1011 x 0.6/9 = 1.2x1010

In our polymerisation assay, we added 5 μl of GFP-g-TuRC eluate to a 50 μl final volume. At t=2 and t=5, we then took 1 μl of this reaction mix and diluted into 200 μl of glutaraldehyde fixative. We then spotted 1 μl of this onto a coverslip. Therefore, the number of g-TuRCs on the coverslip can be estimated as (1.2x1010 x 5)/1000 = 6.0x106.

Given that there was an average of 130 MTs in a field of view at t=2 mins and that the field of view was 60.5 μm2, the 22 mm2 coverslip contains \~1.32x105 fields of view; equating to 1.7x107 MTs per coverslip.

Therefore, within 2 minutes of incubation, 6.0x106 g-TuRCs are able to nucleate 61.7x107 MTs. We state this in two ways in the manuscript: (i) that one TuRC is capable of nucleating 2-3 MTs within 2 minutes, (ii) purified TuRCs nucleate MTs in the assay at \~1MT/min.

We now say: "To calculate this activity, we related the estimated number of γ-TuRCs per field of view to the mean number of MTs (see Materials and methods), These calculations suggest that a single γ-TuRC is able to nucleate multiple (2-3) MTs within 2 minutes (i.e. a rate of \>1MT/min)."

In the final discussion, we state: "Although our calculations suggest that 65% of the mitotic g-TuRCs are competent to bind MT minus ends and Augmin, and that they are able to nucleate at a rate of \> 1MT/min, we expect that, in vivo, other proteins either further enhance these γ-TuRC activities."

In the Materials and methods, we add a section headed: "Estimation of the nucleation efficienct of purified g-TuRC in vitro", providing the detailed calculations above.

We very much hope that the reviewers will look positively on this additional data.
